HIV

The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Latest News

Vaccination | Image credit: Prostock-studio - stock.adobe.com
HPV Vaccination Cost-Effective at Preventing Cervical Cancer in Patients With HIV

November 21st 2024

Women living with HIV can reduce their risk of cervical cancer using a human papillomavirus (HPV) vaccine that is both cost-effective and effective in preventing the virus.

HIV | Image credit: Corona Borealis - stock.adobe.com
New Data Provide Clearer Picture on Adherence to Lenacapavir

November 18th 2024

HIV | Image credit: RAJCREATIONZS - stock.adobe.com
BIC/FTC/TAF Effective at Virologic Suppression in HIV Presenting Late

November 15th 2024

Liver | Image credit: PIC4U - stock.adobe.com
Liver Steatosis, Fibrosis Highly Prevalent in People Living With HIV

November 12th 2024

Madalitso Juwayeyi
Empowering Young Women in the Fight Against HIV

November 8th 2024

Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.

This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.
Continuing Medical Education
View All
November 24th 2024

Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence

1.5 Credits / HIV/AIDS, Infectious Diseases

More News

Podcast: This Week in Managed Care—CMS Drug Coverage Changes Draw Ire and Other Health News
December 1st 2018

Podcast: This Week in Managed Care—CMS Drug Coverage Changes Draw Ire and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Highlighting Progress, Need for Improvement in HIV Epidemic Ahead of World AIDS Day
November 30th 2018

Highlighting Progress, Need for Improvement in HIV Epidemic Ahead of World AIDS Day

Jaime Rosenberg
As the world observes World AIDS Day 2018 on December 1, WalletHub has released an HIV/AIDS report in an effort to increase awareness about the virus.
This Week in Managed Care: November 30, 2018
November 30th 2018

This Week in Managed Care: November 30, 2018

This week, the top managed care news included a CMS plan for changes in drug coverage that brought a wave of criticism; a government task force recommended more people at risk for HIV take pre-exposure prophylaxis, known as PrEP; the American College of Cardiology issued an Expert Consensus Pathway on treatment of patients with type 2 diabetes and atherosclerotic cardiovascular disease.
Top 5 AJMC® Articles of November 2018
November 30th 2018

Top 5 AJMC® Articles of November 2018

Here are the top 5 articles for the month of November.
USPSTF Recommends Clinicians Prescribe HIV PrEP to All High-Risk Patients
November 22nd 2018

USPSTF Recommends Clinicians Prescribe HIV PrEP to All High-Risk Patients

Jaime Rosenberg
The US Preventive Services Task Force (USPSTF) is recommending that clinicians offer the treatment to people at high risk of HIV, which will likely increase access to the treatment for those who need it most.
Cellular Proliferation Drives HIV Persistence During Treatment With ART
November 21st 2018

Cellular Proliferation Drives HIV Persistence During Treatment With ART

Jaime Rosenberg
According to a new study, cellular proliferation generates the majority of infected cells during antiretroviral therapy (ART), suggesting that reducing proliferation can decrease the size of the HIV reservoir and work toward a cure.
Following Release From Incarceration, People Living With HIV Have Higher Mortality Rates Than General Population
November 16th 2018

Following Release From Incarceration, People Living With HIV Have Higher Mortality Rates Than General Population

Alison Rodriguez
Following release from prison or jail, people living with HIV have higher mortality rates than the general population, indicating that resources are needed to identify and treat HIV and other medical needs following release from incarceration in order to reduce mortality.
Provider Stigma Toward HIV Slows Prevention Goals
November 15th 2018

Provider Stigma Toward HIV Slows Prevention Goals

Jaime Rosenberg
As physicians have an essential role in the fight against HIV—leading patients through the care continuum—understanding HIV-related stigma among physicians can inform development of interventions to reduce this stigma and promote positive clinical outcomes.
Advance Care Planning Among Adolescent Patients With HIV Lowers Symptoms, Suffering
November 10th 2018

Advance Care Planning Among Adolescent Patients With HIV Lowers Symptoms, Suffering

Alison Rodriguez
Family-centered pediatric advance care planning increased and maintained agreement about goals of care longitudinally, which lowered adolescents’ physical symptoms and suffering.
Hispanics Living With HIV at Increased Risk of HPV-Related Cancers
November 6th 2018

Hispanics Living With HIV at Increased Risk of HPV-Related Cancers

Jaime Rosenberg
Hispanics living with HIV are at an increased risk of developing cancers caused by the human papillomavirus (HPV) compared to the general Hispanic population, and among people living with HIV, Hispanics are more likely to be diagnosed with cervical and penile cancer.
Researchers Propose Adding Viral Suppression Within 3 Months of HIV Diagnosis to HIV/AIDS Strategy
November 1st 2018

Researchers Propose Adding Viral Suppression Within 3 Months of HIV Diagnosis to HIV/AIDS Strategy

Jaime Rosenberg
Recognizing a need for an outcome indicator for those newly diagnosed with HIV, researchers have proposed including the percentage of newly diagnosed persons achieving viral suppression within 3 months of diagnosis.
Janssen Releases Long-Term AMBER Trial Data Supporting Safety, Efficacy of Symtuza for HIV
October 30th 2018

Janssen Releases Long-Term AMBER Trial Data Supporting Safety, Efficacy of Symtuza for HIV

Jaime Rosenberg
Building on positive 48-week data, Janssen released 96-week data demonstrating high rates of virogolic suppression and tolerability among antiretroviral therapy-naïve adults with HIV-1.
Retention in HIV Care Decreases Over Time Following Release From Incarceration
October 26th 2018

Retention in HIV Care Decreases Over Time Following Release From Incarceration

Jaime Rosenberg
Following more than 1000 people living with HIV who were recently incarcerated, researchers observed that retention in care diminished significantly over time, but it was associated with HIV care during incarceration, health insurance, case management services, and early linkage to care post release.
Immunotherapy Is Safe for Patients With Cancer Living With HIV
October 25th 2018

Immunotherapy Is Safe for Patients With Cancer Living With HIV

Jaime Rosenberg
According to a study presented at the ESMO 2018 Congress in Munich, Germany, treatment with PD-1 or PD-L1 inhibitors is a feasible option for patients who have cancer and are living with HIV.
Site Logo
October 23rd 2018

Drug Market to See More Competition, Launch of Biosimilars in 2019

Mary Caffrey
Express Scripts' Aimee Tharaldson, PharmD, gave her overview of the specialty pharmacy pipeline for 2019 and beyond at the Academy of Managed Care Pharmacy Nexus 2018 meeting in Orlando, Florida.
Population-Level PrEP Roll-Out Associated With Rapid Decline in HIV Diagnoses
October 18th 2018

Population-Level PrEP Roll-Out Associated With Rapid Decline in HIV Diagnoses

Jaime Rosenberg
A population-level roll-out of pre-exposure prophylaxis (PrEP) for HIV in men who have sex with men resulted in a 25% reduction in HIV diagnoses in just 1 year.
Trial Will Examine Novel HIV Vaccine Candidate Designed to Stimulate Immune Response
October 17th 2018

Trial Will Examine Novel HIV Vaccine Candidate Designed to Stimulate Immune Response

Jaime Rosenberg
The novel vaccine—eOD-GT8 60mer—stimulates the immune system to initiate a key first step in the generation of potent proteins, known as broadly neutralizing antibodies.
HHS Awards $2.34 Billion in Grants to Ryan White HIV/AIDS Program
October 12th 2018

HHS Awards $2.34 Billion in Grants to Ryan White HIV/AIDS Program

Jaime Rosenberg
Today, HHS announced that approximately $2.34 billion in Ryan White HIV/AIDS Program grants were awarded to cities, counties, states, and local community-based organizations during fiscal year 2018.
Symtuza Achieves, Maintains Viral Suppression in Patients With HIV
October 9th 2018

Symtuza Achieves, Maintains Viral Suppression in Patients With HIV

Jaime Rosenberg
Treatment with Symtuza (darunavir 800 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir alafenamide 10 mg) results in and maintains high virologic suppression rates, according to study findings presented at the 2018 Infectious Disease Week conference held in San Francisco, California.
Collaborative, Multidisciplinary Care Has Positive Impact on Viral Suppression in HIV
October 3rd 2018

Collaborative, Multidisciplinary Care Has Positive Impact on Viral Suppression in HIV

Jaime Rosenberg
Two studies presented at the 2018 Infectious Disease Week conference held in San Francisco, California, add to a pile of research demonstrating the positive impact of collaborative, multidisciplinary care in the HIV population, specifically on viral suppression.
People Living With HIV Have Higher Risk of First and Second Primary Cancer Incidence
October 2nd 2018

People Living With HIV Have Higher Risk of First and Second Primary Cancer Incidence

Jaime Rosenberg
A new study has found that people living with HIV are at an increased risk of both first and second primary cancer incidence.
Text Message Intervention Improves PrEP Adherence Among MSM at Risk for HIV
September 28th 2018

Text Message Intervention Improves PrEP Adherence Among MSM at Risk for HIV

Jaime Rosenberg
Young men who have sex with men (MSM) who used the PrEPmate intervention were more likely to attend study visits and have higher rates of adherence to the prevention treatment.
Unstable Housing Has Adverse Impact on Viral Suppression, CD4 Cell Count in HIV Population
September 24th 2018

Unstable Housing Has Adverse Impact on Viral Suppression, CD4 Cell Count in HIV Population

Jaime Rosenberg
Unstable housing among the HIV population is associated with decreased probability of viral suppression and adequate CD4 cell count. It also lowers the likelihood of mental health/counseling, visiting a healthcare provider, and engaging in continuity of care.
Podcast: This Week in Managed Care—Banning Gag Clauses and Other Health News
September 22nd 2018

Podcast: This Week in Managed Care—Banning Gag Clauses and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This Week in Managed Care: September 21, 2018
September 21st 2018

This Week in Managed Care: September 21, 2018

This week, the top managed care news included the Senate overwhelmingly voting to ban pharmacist gag clauses; a study found the current vaccine pipeline for HIV, tuberculosis, and malaria may fall short; an expert noted a trend of healthcare cost data seeping into nonhealthcare companies’ earnings calls.
More Than 25% of HIV Providers Don't Know If Their State Expanded Medicaid
September 20th 2018

More Than 25% of HIV Providers Don't Know If Their State Expanded Medicaid

Jaime Rosenberg
A survey has revealed gaps in HIV providers’ knowledge of the Affordable Care Act. However, despite these gaps, the majority of surveyed providers expressed belief that Medicaid expansion would improve both HIV outcomes and general outcomes for patients with the disease.
Launch of Highly Efficacious HIV, Tuberculosis, and Malaria Vaccines Unlikely, Study Says
September 18th 2018

Launch of Highly Efficacious HIV, Tuberculosis, and Malaria Vaccines Unlikely, Study Says

Jaime Rosenberg
Researchers determined that the current drug pipeline is unlikely to produce any highly effective vaccines for HIV, tuberculosis, or malaria, which could be important for controlling the spread of these diseases.
Medication Adherence Program for HIV Needs Collaboration Among Physicians, Nurses, and Pharmacists
September 15th 2018

Medication Adherence Program for HIV Needs Collaboration Among Physicians, Nurses, and Pharmacists

David Bai
A descriptive, observational study in Switzerland implemented an interprofessional medication adherence program (IMAP) in patients with HIV. The framework for the implementation of services in pharmacy (FISpH) model is described and formulated for other healthcare facilities and professionals to evaluate and execute for themselves.
AJMC® in the Press, September 14, 2018
September 14th 2018

AJMC® in the Press, September 14, 2018

AJMC Staff
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
California Medicaid Expansion Had Mixed Effects for HIV Population
September 11th 2018

California Medicaid Expansion Had Mixed Effects for HIV Population

Jaime Rosenberg
With the expansion of Medicaid, eligible, low-income people living with HIV were transferred from the Ryan White Program to Medicaid, causing concern for interrupted access to care and treatment.
<1
...
181920212223242526
...
30>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo